Vascular dementia: Molecular targets of neuroprotective therapy
- 作者: Gomazkov O.A.1, Lagunin A.A.1
-
隶属关系:
- Institute of Biomedical Chemistry
- 期: 卷 7, 编号 6 (2017)
- 页面: 528-536
- 栏目: Article
- URL: https://journals.rcsi.science/2079-0864/article/view/206601
- DOI: https://doi.org/10.1134/S2079086417060032
- ID: 206601
如何引用文章
详细
Vascular dementia is considered a heterogeneous group of brain diseases in which a cognitive deficit appears because of cerebrovascular disorders caused by chronic hypoperfusion. The pathogenesis includes a complex of processes from changes in cerebral hemodynamics to discordance of neural networks and cognitive disorders. The modern concept of vascular dementia discriminates molecular links of disturbed regulatory and signaling pathways in the brain. The prospective therapeutic targets relate to the regulation of metabolism, signaling molecules of extra- and intracellular control, immune response, apoptosis, and longterm memory. The limitations of current therapeutic agents for dementia can be supplemented by data on pharmacological targets and the opportunity for correction of disturbed processes in the brain.
作者简介
O. Gomazkov
Institute of Biomedical Chemistry
编辑信件的主要联系方式.
Email: oleg-gomazkov@yandex.ru
俄罗斯联邦, Moscow
A. Lagunin
Institute of Biomedical Chemistry
Email: oleg-gomazkov@yandex.ru
俄罗斯联邦, Moscow
补充文件
